OBJECTIVE: Describe characteristics, daily care and outcomes of patients with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS). DESIGN: Case series of 73 patients. SETTING: Large tertiary hospital in Milan. PARTICIPANTS: Mechanically ventilated patients with confirmed COVID-19 admitted to the intensive care unit (ICU) between 20 February and 2 April 2020. MAIN OUTCOME MEASURES: Demographic and daily clinical data were collected to identify predictors of early mortality. RESULTS: Of the 73 patients included in the study, most were male (83.6%), the median age was 61 years (interquartile range [IQR], 54-69 years), and hypertension affected 52.9% of patients. Lymphocytopenia (median, 0.77 x 103 per mm3 ; IQR, 0.58-1.00 x 103 per mm3), hyperinflammation with C-reactive protein (median, 184.5 mg/dL; IQR, 108.2-269.1 mg/dL) and pro-coagulant status with D-dimer (median, 10.1 μg/m; IQR, 5.0-23.8 μg/m) were present. Median tidal volume was 6.7 mL/kg (IQR, 6.0-7.5 mL/kg), and median positive end-expiratory pressure was 12 cmH2O (IQR, 10-14 cmH2O). In the first 3 days, prone positioning (12-16 h) was used in 63.8% of patients and extracorporeal membrane oxygenation in five patients (6.8%). After a median follow-up of 19.0 days (IQR, 15.0-27.0 days), 17 patients (23.3%) had died, 23 (31.5%) had been discharged from the ICU, and 33 (45.2%) were receiving invasive mechanical ventilation in the ICU. Older age (odds ratio [OR], 1.12; 95% CI, 1.04-1.22; P = 0.004) and hypertension (OR, 6.15; 95% CI, 1.75-29.11; P = 0.009) were associated with mortality, while early improvement in arterial partial pressure of oxygen (PaO2) to fraction of inspired oxygen (FiO2) ratio was associated with being discharged alive from the ICU (P = 0.002 for interaction). CONCLUSIONS: Despite multiple advanced critical care interventions, COVID-19 ARDS was associated with prolonged ventilation and high short term mortality. Older age and pre-admission hypertension were key mortality risk factors. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT04318366.
OBJECTIVE: Describe characteristics, daily care and outcomes of patients with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS). DESIGN: Case series of 73 patients. SETTING: Large tertiary hospital in Milan. PARTICIPANTS: Mechanically ventilated patients with confirmed COVID-19 admitted to the intensive care unit (ICU) between 20 February and 2 April 2020. MAIN OUTCOME MEASURES: Demographic and daily clinical data were collected to identify predictors of early mortality. RESULTS: Of the 73 patients included in the study, most were male (83.6%), the median age was 61 years (interquartile range [IQR], 54-69 years), and hypertension affected 52.9% of patients. Lymphocytopenia (median, 0.77 x 103 per mm3 ; IQR, 0.58-1.00 x 103 per mm3), hyperinflammation with C-reactive protein (median, 184.5 mg/dL; IQR, 108.2-269.1 mg/dL) and pro-coagulant status with D-dimer (median, 10.1 μg/m; IQR, 5.0-23.8 μg/m) were present. Median tidal volume was 6.7 mL/kg (IQR, 6.0-7.5 mL/kg), and median positive end-expiratory pressure was 12 cmH2O (IQR, 10-14 cmH2O). In the first 3 days, prone positioning (12-16 h) was used in 63.8% of patients and extracorporeal membrane oxygenation in five patients (6.8%). After a median follow-up of 19.0 days (IQR, 15.0-27.0 days), 17 patients (23.3%) had died, 23 (31.5%) had been discharged from the ICU, and 33 (45.2%) were receiving invasive mechanical ventilation in the ICU. Older age (odds ratio [OR], 1.12; 95% CI, 1.04-1.22; P = 0.004) and hypertension (OR, 6.15; 95% CI, 1.75-29.11; P = 0.009) were associated with mortality, while early improvement in arterial partial pressure of oxygen (PaO2) to fraction of inspired oxygen (FiO2) ratio was associated with being discharged alive from the ICU (P = 0.002 for interaction). CONCLUSIONS: Despite multiple advanced critical care interventions, COVID-19 ARDS was associated with prolonged ventilation and high short term mortality. Older age and pre-admission hypertension were key mortality risk factors. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT04318366.
Entities:
Keywords:
Anesthesia and intensive care; COVID-19; ICU; SARS-CoV-2
Authors: Osama El Shamy; Niralee Patel; Mohamed Halim Abdelbaset; Linda Chenet; Joji Tokita; Robert Lookstein; David S Lee; Noah A Cohen; Shuchita Sharma; Jaime Uribarri Journal: J Am Soc Nephrol Date: 2020-06-16 Impact factor: 10.121
Authors: Eumelia P Salva; Jose Benito Villarama; Edmundo B Lopez; Ana Ria Sayo; Annavi Marie G Villanueva; Tansy Edwards; Su Myat Han; Shuichi Suzuki; Xerxes Seposo; Koya Ariyoshi; Chris Smith Journal: Trop Med Health Date: 2020-06-22
Authors: Qiangzhe Zhang; Anna Honko; Jiarong Zhou; Hua Gong; Sierra N Downs; Jhonatan Henao Vasquez; Ronnie H Fang; Weiwei Gao; Anthony Griffiths; Liangfang Zhang Journal: Nano Lett Date: 2020-06-17 Impact factor: 11.189
Authors: Job van Steenkiste; Michael C van Herwerden; Dolf Weller; Christiaan J van den Bout; Rikje Ruiter; Jan G den Hollander; Rachida El Moussaoui; Gert T Verhoeven; Charlotte van Noord; Marinus A van den Dorpel Journal: Heart Lung Date: 2021-05-25 Impact factor: 2.210
Authors: Fermín Sánchez-Guijo; Mariano García-Arranz; Miriam López-Parra; Pablo Monedero; Carmen Mata-Martínez; Arnoldo Santos; Víctor Sagredo; José-Manuel Álvarez-Avello; José Eugenio Guerrero; César Pérez-Calvo; Miguel-Vicente Sánchez-Hernández; José Luis Del-Pozo; Enrique J Andreu; María-Eugenia Fernández-Santos; Barbara Soria-Juan; Luis M Hernández-Blasco; Etelvina Andreu; José M Sempere; Agustín G Zapata; José M Moraleda; Bernat Soria; Francisco Fernández-Avilés; Damián García-Olmo; Felipe Prósper Journal: EClinicalMedicine Date: 2020-07-10